SIBO: Small Intestinal Bacterial Overgrowth and Gut Dysfunction

Overview

The modern landscape of gastroenterology is currently grappling with an epidemic that is as misunderstood as it is pervasive. Small Intestinal Bacterial Overgrowth (SIBO) is not merely a "digestive quirk" or a minor imbalance; it is a profound disruption of the biological architecture of the human gut. For decades, patients presenting with chronic bloating, debilitating abdominal pain, and systemic fatigue were often dismissed with a vague diagnosis of Irritable Bowel Syndrome (IBS). However, emerging research—and the data that the mainstream medical establishment has been slow to integrate—reveals that up to 80% of IBS cases are actually caused by SIBO.

In a healthy biological system, the small intestine is relatively sterile compared to the densely populated colon. It is a zone of high-velocity transit, precise enzymatic action, and nutrient absorption. SIBO represents a catastrophic failure of these protective mechanisms, where bacteria from the large intestine migrate upwards, or indigenous small-bowel bacteria proliferate to pathological levels. This is not a "passive" infection; it is a metabolic hijacking. These bacteria consume the nutrients meant for the host, produce toxic fermentation by-products, and damage the delicate microvilli of the intestinal wall.

The implications extend far beyond the gut. Because 70% of the human immune system resides in the gut-associated lymphoid tissue (GALT), the presence of chronic overgrowth triggers a systemic inflammatory cascade. We are witnessing a rise in autoimmune conditions, neurological "brain fog," and chronic nutrient deficiencies that trace their lineage directly back to the architectural failure of the small intestine. At INNERSTANDING, we recognise that SIBO is an environmental and biological signal—a warning that our internal ecology is being dismantled by a combination of pharmaceutical over-reliance, environmental toxins, and a misunderstanding of human motility.

##

##

The Biology — How It Works

To understand SIBO, one must first understand the "biological geography" of the gastrointestinal tract. The human gut is a gradient. The stomach is highly acidic (pH 1.5–3), which serves as the primary chemical barrier against ingested pathogens. As we move into the small intestine—comprising the duodenum, jejunum, and ileum—the environment remains relatively hostile to massive bacterial colonisation due to the presence of bile acids and rapid transit. The large intestine (colon), by contrast, is a slow-moving reservoir where trillions of bacteria thrive to break down fibre.

The primary mechanism preventing the "backflow" of colonic bacteria into the small intestine is the Ileocecal Valve (ICV). When this anatomical gate becomes "stuck" open due to inflammation or neurological dysfunction, the small intestine is flooded with colonic flora. However, the more common driver is the failure of the Migrating Motor Complex (MMC).

The Migrating Motor Complex: The Housekeeper Wave

The MMC is a distinct electrical and muscular pattern of activity that occurs in the small intestine during periods of fasting (between meals and overnight). It is often referred to as the "intestinal housekeeper." Its role is to sweep undigested food particles and excess bacteria out of the small intestine and into the colon.

The MMC consists of four phases, with Phase III being the most critical—a series of high-amplitude contractions that act as a physical purge. In the SIBO patient, the MMC is often absent or severely diminished. This stasis allows bacteria to take up permanent residence, forming biofilms—protective slimy coatings that make them resistant to both the body’s immune response and standard antibiotic treatments.

The Bacterial Players

In SIBO, the overgrowth typically involves several key species:

• —Hydrogen-producing bacteria: Such as *Escherichia coli* and *Klebsiella pneumoniae*. These thrive on sugars and starches, producing hydrogen gas as a metabolic waste product.
• —Methane-producing archaea: Specifically *Methanobrevibacter smithii*. Technically not bacteria but ancient single-celled organisms, these "methanogens" consume the hydrogen produced by other bacteria and exhale methane. Methane is a gas that acts as a paralytic to the gut, slowing transit time and leading to chronic constipation.
• —Hydrogen Sulfide producers: Species like *Desulfovibrio* and *Bilophila wadsworthia*. These produce a highly toxic gas that smells like rotten eggs and is directly damaging to the mitochondria of the intestinal cells.

##

##

Mechanisms at the Cellular Level

At the cellular level, SIBO is a war of attrition against the enterocytes (the cells lining the small intestine). The damage is orchestrated through several distinct biochemical pathways that the mainstream narrative often fails to articulate in detail.

Deconjugation of Bile Acids

One of the most devastating effects of SIBO is the deconjugation of bile acids. Bacteria, particularly certain Gram-positive and Gram-negative strains, produce an enzyme called bile salt hydrolase. This enzyme breaks the bond between bile salts and the amino acids glycine or taurine. When bile is deconjugated prematurely in the small intestine, it loses its ability to emulsify fats. This leads to:

• —Steatorrhea: Malabsorption of fats, resulting in oily or floating stools.
• —Deficiency in Fat-Soluble Vitamins: A total failure to absorb Vitamins A, D, E, and K, which are critical for immune function, bone health, and blood clotting.
• —Mitochondrial Toxicity: Deconjugated bile acids are toxic to the intestinal lining, causing direct cellular apoptosis (cell death).

The Destruction of the Brush Border

The lining of the small intestine is covered in microscopic, finger-like projections called microvilli, which form the brush border. This is where the final stage of digestion occurs, facilitated by enzymes like lactase, sucrase, and maltase. In SIBO, the overgrowing bacteria physically "brush off" these enzymes. They also produce proteases that degrade the transporters responsible for moving nutrients from the gut lumen into the bloodstream. This creates a state of functional malabsorption. The patient may be eating a nutrient-dense diet, but at a cellular level, they are starving because their transport proteins (like GLUT5 for fructose or SGLT1 for glucose) are being dismantled.

Lipopolysaccharides (LPS) and Systemic Endotoxemia

The bacteria involved in SIBO are often Gram-negative, meaning their outer cell wall contains Lipopolysaccharides (LPS). LPS is one of the most potent pro-inflammatory substances known to biology. When these bacteria die or replicate in the small intestine, LPS is released. In a healthy gut, the mucosal barrier prevents LPS from entering the blood. However, SIBO-induced inflammation triggers the release of Zonulin, a protein that modulates the "tight junctions" between intestinal cells. As zonulin levels rise, the tight junctions open—a state known as Intestinal Permeability or "Leaky Gut." LPS then floods the portal circulation, reaching the liver and the systemic bloodstream. This is the biological mechanism behind "brain fog," as LPS can cross the blood-brain barrier and activate the brain's immune cells (microglia), leading to neuroinflammation.

##

##

Environmental Threats and Biological Disruptors

The sudden surge in SIBO cases across the UK and the Western world is not a biological accident. It is the result of a coordinated assault on our internal ecosystem by environmental factors that have become inescapable.

The Glyphosate Factor

Glyphosate, the active ingredient in many broad-spectrum herbicides used extensively in UK agriculture, is a primary culprit. While the industry claims glyphosate is safe because humans do not possess the Shikimate pathway (which the chemical targets), our gut bacteria *do* possess this pathway. Glyphosate acts as a selective antibiotic. It disproportionately kills beneficial species like *Lactobacillus* and *Bifidobacterium*, while allowing pathogenic, SIBO-associated strains like *Salmonella* and *Clostridia* to flourish. Furthermore, glyphosate has been shown to chelate (bind) essential minerals like manganese and zinc, which are required for the production of digestive enzymes and the maintenance of the intestinal barrier.

Proton Pump Inhibitors (PPIs) and the Death of the Acid Barrier

In the UK, PPIs like Omeprazole and Lansoprazole are among the most commonly prescribed medications. By inhibiting the H+/K+-ATPase pump in the stomach, these drugs virtually eliminate stomach acid. Mainstream medicine views stomach acid as an "enemy" to be suppressed in cases of reflux. Biological reality dictates that stomach acid is our first line of defence against SIBO. Without sufficient hydrochloric acid (HCl), the stomach fails to sterilise food, and the pH of the small intestine shifts toward a more alkaline state that favours bacterial colonisation.

Chlorinated Water and the Microbiome

The UK’s water supply is treated with chlorine and chloramines to eliminate waterborne pathogens. While effective for public safety, these chemicals do not differentiate between harmful environmental bacteria and the delicate flora of the human gut. Chronic exposure to chlorinated tap water acts as a "low-dose antibiotic" that continuously disrupts the mucosal layer of the small intestine, making it easier for opportunistic bacteria to take hold.

The Role of Microplastics

Recent research from the UK's Environment Agency and academic institutions has highlighted the ubiquity of microplastics in our food chain. These particles have been found to act as "scaffolding" for bacterial biofilms. When microplastics lodge in the mucus layer of the small intestine, they provide a physical structure that protects SIBO-related bacteria from the host's immune cells and antimicrobial peptides like alpha-defensins.

##

##

The Cascade: From Exposure to Disease

SIBO does not happen overnight. It is a "cascading" failure of multiple biological systems. Understanding this sequence is vital for anyone seeking recovery.

Step 1: The Insult (Trigger)

The cascade often begins with an acute event. This could be a bout of food poisoning (infective gastroenteritis) caused by *Campylobacter*, *Salmonella*, or *Shigella*. These pathogens produce a toxin called Cytolethal Distending Toxin B (CdtB). Through a process called "molecular mimicry," the human body produces antibodies to fight CdtB that inadvertently attack a protein called Vinculin. Vinculin is essential for the function of the Interstitial Cells of Cajal—the "pacemakers" of the gut. This leads to permanent or semi-permanent damage to the Migrating Motor Complex.

Step 2: Stasis and Fermentation

Once the MMC is damaged, the "housekeeper wave" stops. Food residues and bacteria sit in the warm, moist environment of the small intestine. This is biological stasis. The bacteria begin to ferment carbohydrates, producing gases (H2, CH4). This fermentation is not benign; it causes the small intestine to distend. This distension causes the physical pain and visible "pregnant look" bloating characteristic of SIBO.

Step 3: Malabsorption and Toxaemia

The expanding bacterial population begins to consume the host's B12 and iron. The gases produced damage the brush border. The bile acids are deconjugated. At this stage, the patient begins to experience systemic symptoms:

• —Restless Leg Syndrome (RLS): Often linked to the iron deficiency and inflammatory markers caused by SIBO.
• —Histamine Intolerance: The damaged brush border can no longer produce Diamine Oxidase (DAO), the enzyme that breaks down histamine in food.
• —Oxalate Sensitivity: Fat malabsorption leads to calcium binding to fats instead of oxalates. The free oxalates are then absorbed into the bloodstream, where they can form crystals in joints or the kidneys.

Step 4: The Immune Collapse

Finally, the chronic leak of LPS into the bloodstream keeps the immune system in a state of constant "High Alert." This leads to the exhaustion of the adrenal glands (HPA axis dysregulation) and can eventually trigger autoimmune responses as the immune system loses the ability to distinguish between "self" and "non-self" amidst the constant flood of bacterial debris.

##

##

What the Mainstream Narrative Omits

The mainstream medical approach to SIBO is fundamentally flawed because it views the condition as a "static infection" rather than a "dynamic system failure."

The "Rifaximin Only" Fallacy

The standard of care often involves a 14-day course of the antibiotic Rifaximin. While Rifaximin is unique because it is non-absorbable and stays in the gut, the relapse rate is staggeringly high—estimated at over 40% within the first few months. Why? Because the mainstream narrative ignores the root cause. If the Migrating Motor Complex is not restored, the bacteria will simply grow back within weeks. Killing the bacteria without fixing the "sweep" is like mopping the floor while the tap is still running.

The Fibre Myth

Patients are often told to "eat more fibre" to improve their digestion. In the context of SIBO, this is some of the most damaging advice possible. Fibre is the primary fuel source for the very bacteria that are overgrowing. Adding fibre to an active SIBO case is like throwing petrol on a bonfire. It increases gas production, increases distension, and further slows motility.

The Role of Stress as a Biological Force

Mainstream medicine often categorises "stress" as a psychological byproduct. In reality, stress is a biological force that directly inhibits the Vagus Nerve. The Vagus Nerve is the primary conduit for the "rest and digest" system. When the body is in a state of sympathetic (fight or flight) dominance, the Vagus nerve signals to the gut to *stop* the MMC. Therefore, a patient can have the "perfect" diet and the strongest antimicrobials, but if their nervous system is stuck in a stress response, their MMC will remain dormant, and SIBO will persist.

The Neglect of Biofilms

Standard diagnostic and treatment protocols rarely account for biofilms. These are sophisticated bacterial communities that encapsulate themselves in a matrix of DNA, proteins, and polysaccharides. Bacteria within a biofilm can be up to 1,000 times more resistant to antibiotics than "planktonic" (free-floating) bacteria. Failure to use biofilm-disrupting agents is a primary reason for treatment "resistance."

##

##

The UK Context

Navigating SIBO in the United Kingdom presents a unique set of challenges, largely due to the structured nature of the NHS and the lag in updating clinical guidelines.

The NHS Struggle

Currently, SIBO is not universally recognised or tested for within the primary care (GP) setting. Most GPs are trained to look for "red flags" like Crohn’s disease or Coeliac disease via blood tests (CRP, ESR) or calproctectin stool tests. SIBO, however, often presents with "normal" inflammatory markers on standard tests. The "gold standard" for SIBO diagnosis is the Lactulose Breath Test. While some NHS trusts offer this, the wait times can exceed 18 weeks, and the interpretation of the results often fails to account for the "flat-line" result (which can indicate hydrogen sulfide SIBO).

Regulatory Gaps: MHRA and FSA

The Medicines and Healthcare products Regulatory Agency (MHRA) and the Food Standards Agency (FSA) have strict rules on "health claims" for supplements. This often prevents high-quality herbal antimicrobials—which have been shown in John Hopkins University studies to be as effective as Rifaximin—from being marketed effectively for SIBO. Furthermore, the UK's high consumption of ultra-processed foods, which are laden with emulsifiers like Polysorbate 80 and Carboxymethylcellulose, contributes to the SIBO epidemic. These additives, approved by the FSA, have been shown to thin the protective mucus layer of the gut, providing an "open door" for bacterial overgrowth.

The Private Sector and Functional Medicine

Because of the gaps in the NHS, many UK patients are forced into the private sector. While this allows for more advanced testing (such as the Trio-Smart breath test which measures all three gases), it creates a two-tier system where only those with financial means can access true "root-cause" resolution.

##

##

Protective Measures and Recovery Protocols

Recovery from SIBO requires a multi-phased biological strategy. It is not about "killing" alone; it is about "rehabilitation" of the intestinal environment.

Phase 1: Preparation and Biofilm Disruption

Before introducing antimicrobials, the bacterial "fortresses" must be dismantled.

• —Biofilm Disruptors: Agents like Bismuth subnitrate, Alpha-lipoic acid, and N-acetyl cysteine (NAC) help to break down the protective matrix.
• —Phase 1 Diet: Reducing high-fermentation fuels (FODMAPs) temporarily to "starve" the overgrowth and reduce symptomatic distress.

Phase 2: Targeted Eradication

This phase involves either pharmaceutical or herbal antimicrobials.

• —Herbal Protocol: Research supports the use of high-dose Allicin (from garlic), Berberine (from Goldenseal or Oregon Grape), and Neem. These should be rotated to prevent bacterial adaptation.
• —Specific Gas Targeting: Methane cases require a combination of Allicin and Berberine, as methane-producers are archaea and respond differently than standard bacteria.

Phase 3: Prokinetic Support (The Most Critical Step)

To prevent relapse, the Migrating Motor Complex must be re-engaged. This is done using prokinetics—substances that stimulate the "housekeeper wave."

• —Pharmaceutical Prokinetics: Low-dose Erythromycin or Prucalopride (Resolor), taken at bedtime on an empty stomach.
• —Natural Prokinetics: High-dose Ginger root and Artichoke extract. These have been shown to sensitise the nerves in the gut to trigger contractions.

Phase 4: Structural and Vagal Repair

• —Vagus Nerve Stimulation: Techniques such as cold-water immersion, gargling, and deep diaphragmatic breathing are essential to shift the body back into a parasympathetic state.
• —Visceral Osteopathy: Physical manipulation of the ileocecal valve and the small intestine can help release physical adhesions (often from previous surgeries or endometriosis) that contribute to stasis.
• —Mucosal Repair: Using L-Glutamine, Zinc Carnosine, and Serum-derived Bovine Immunoglobulins (SBI) to seal the tight junctions and repair the brush border once the overgrowth is cleared.

##

##

Summary: Key Takeaways

SIBO is a profound biological warning sign that the modern human environment is incompatible with our evolutionary digestive blueprint. It is a condition defined by displacement, where the right organisms end up in the wrong place due to a failure of our internal "housekeeping" systems.

The resolution of SIBO is not found in a single bottle of pills, but in a comprehensive understanding of the Migrating Motor Complex, the pH of the stomach, and the impact of environmental toxins like glyphosate. We must move beyond the "IBS" umbrella and demand specific, gas-based testing and motility-focused recovery protocols.

• —Recognising the failure of the MMC as the primary driver of overgrowth.
• —Addressing the systemic impact of LPS and deconjugated bile acids.
• —Eliminating environmental disruptors such as chlorinated water and unnecessary PPIs.
• —Restoring the Vagus nerve function to ensure long-term intestinal clearance.

The truth is that our guts are not "broken" by chance; they are being suppressed by a system that prioritises symptom management over biological restoration. At INNERSTANDING, we advocate for the reclamation of intestinal sovereignty through science-backed, uncompromising biological truths.